Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Plasma concentrations of gut hormones acyl ghrelin and peptide YY and subsequent risk of colorectal cancer and molecular tumor subtypes
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper, Onkologi.ORCID-id: 0000-0002-8958-975x
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper, Onkologi.ORCID-id: 0000-0002-4759-2643
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper, Onkologi.
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper, Onkologi.
Visa övriga samt affilieringar
2023 (Engelska)Ingår i: Cancer Prevention Research, ISSN 1940-6207, E-ISSN 1940-6215, Vol. 16, nr 2, s. 75-87Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Obesity and metabolic dysfunction are implicated in colorectal cancer development. Appetite-regulating gut hormones might have a role in colorectal cancer risk. We investigated whether circulating levels of the gut hormones ghrelin (analyzed as acyl ghrelin) and Peptide YY (PYY) were associated with subsequent colorectal cancer risk, including clinical and molecular tumor subtypes. We also provide descriptive data on these hormones in relation to background participant characteristics and metabolic biomarkers. This population-based study included 1,010 matched case-control pairs with a median of 12.3 years of follow-up. Acyl ghrelin and PYY were measured by multiplex immunoassay. Data on KRAS and BRAF mutations and microsatellite instability (MSI) status were available for 704 and 708 cases, respectively. Conditional logistic regression models estimated association to colorectal cancer risk. Partial correlation and linear regression were used to investigate relationships between background and metabolic variables and variation in plasma gut hormone concentrations. Acyl ghrelin was not clearly associated with colorectal cancer risk (multivariable OR per 1 SD increase: 1.11; 95% CI, 1.00-1.23). Positive associations were observed for specific subtypes, in particular BRAF-mutated colorectal cancer and right-sided colon cancer, although with nonsignificant heterogeneity. PYY was not related to colorectal cancer risk (multivariable OR per 1 SD: 1.04; 95% CI, 0.95-1.14) or any tumor subtype. In the control participants, ghrelin was inversely correlated with BMI, and PYY was positively correlated with C-peptide and insulin levels. These findings provide limited support for a possible role for ghrelin in colorectal cancer development, primarily in specific anatomical and molecular tumor subtypes.

PREVENTION RELEVANCE: The findings of this study do not support a major role for the metabolic gut hormones ghrelin and PYY in colorectal cancer development but suggest the possibility of an involvement for ghrelin in specific tumor subtypes. Elucidating subtype-specific risk factors and mechanisms of carcinogenesis may have implications for precision prevention.

Ort, förlag, år, upplaga, sidor
American Association for Cancer Research , 2023. Vol. 16, nr 2, s. 75-87
Nationell ämneskategori
Cancer och onkologi
Identifikatorer
URN: urn:nbn:se:umu:diva-204740DOI: 10.1158/1940-6207.CAPR-22-0325ISI: 000928164800001PubMedID: 36367526Scopus ID: 2-s2.0-85147457884OAI: oai:DiVA.org:umu-204740DiVA, id: diva2:1738578
Forskningsfinansiär
Region VästerbottenUmeå universitetCancerfonden, 2017/ 581Cancerfonden, 2014/780Cancerfonden, 2012/0501Cancerforskningsfonden i Norrland, AMP 21-1039Cancerforskningsfonden i Norrland, AMP 20-1015Cancerforskningsfonden i Norrland, AMP 19-984Knut och Alice Wallenbergs StiftelseTillgänglig från: 2023-02-22 Skapad: 2023-02-22 Senast uppdaterad: 2023-09-05Bibliografiskt granskad

Open Access i DiVA

fulltext(1004 kB)79 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 1004 kBChecksumma SHA-512
ca0e25c46642e0678a246919d23ca09c7a2745129e73747187fd788f6718f70dbd06ca7400668cb68d619e04de3cb1e3207c5d7402a18db229abf01bc3afba1b
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Bodén, StinaHarbs, JustinSundkvist, AnneliMyte, RobinGylling, BjörnZingmark, CarlLöfgren Burström, AnnaPalmqvist, RichardHarlid, Sophiavan Guelpen, Bethany

Sök vidare i DiVA

Av författaren/redaktören
Bodén, StinaHarbs, JustinSundkvist, AnneliMyte, RobinGylling, BjörnZingmark, CarlLöfgren Burström, AnnaPalmqvist, RichardHarlid, Sophiavan Guelpen, Bethany
Av organisationen
OnkologiPatologiWallenberg centrum för molekylär medicin vid Umeå universitet (WCMM)
I samma tidskrift
Cancer Prevention Research
Cancer och onkologi

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 79 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 401 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf